These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 30238767

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™.
    Goldhaber SZ, Eriksson H, Kakkar A, Schellong S, Feuring M, Fraessdorf M, Kreuzer J, Schueler E, Schulman S.
    Vasc Med; 2016 Dec; 21(6):506-514. PubMed ID: 27807306
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Association between Renal Function and Bleeding Risk for Dabigatran after Switching from Warfarin.
    Kalil RS, Kaboli PJ, Liu X, Vaughan-Sarrazin M.
    Am J Nephrol; 2016 Dec; 44(1):11-8. PubMed ID: 27344150
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Real Data on Effectiveness, Tolerability and Safety of New Oral Anticoagulant Agents: Focus on Dabigatran.
    Stabile E, Izzo R, Rozza F, Losi MA, Coscioni E, Trimarco B.
    High Blood Press Cardiovasc Prev; 2016 Jun; 23(2):115-22. PubMed ID: 27207360
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Spontaneous Cervical Spinal Epidural Hematoma Associated with Dabigatran.
    Mathais Q, Esnault P, Cruc M, Bernard C, Prunet B, Gaillard PE.
    World Neurosurg; 2018 Apr; 112():264-266. PubMed ID: 29425981
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer.
    Schulman S, Goldhaber SZ, Kearon C, Kakkar AK, Schellong S, Eriksson H, Hantel S, Feuring M, Kreuzer J.
    Thromb Haemost; 2015 Jul; 114(1):150-7. PubMed ID: 25739680
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Renal function monitoring in patients prescribed dabigatran in the Compass Health Primary Health Organisation: a quality improvement audit.
    McBain L, Kyle A.
    N Z Med J; 2018 Mar 09; 131(1471):40-47. PubMed ID: 29518798
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Dabigatran etexilate: An alternative to warfarin for patients with nonvalvular atrial fibrillation.
    Scott KA, Amirehsani KA.
    J Am Assoc Nurse Pract; 2015 Apr 09; 27(4):190-6. PubMed ID: 25066647
    [Abstract] [Full Text] [Related]

  • 56. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
    Maura G, Blotière PO, Bouillon K, Billionnet C, Ricordeau P, Alla F, Zureik M.
    Circulation; 2015 Sep 29; 132(13):1252-60. PubMed ID: 26199338
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Management of Major Bleeding Related to Novel Oral Anticoagulant Agents Use in Frail Elderly Adults.
    Wang L, Xie Y, Pan H.
    J Am Geriatr Soc; 2016 Oct 29; 64(10):e105-e107. PubMed ID: 27685081
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
    Coleman CI, Peacock WF, Bunz TJ, Alberts MJ.
    Stroke; 2017 Aug 29; 48(8):2142-2149. PubMed ID: 28655814
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.